Figure 2
From: Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model
In vitro effects of single or combination treatments containing177Lu-DOTA-chCE7 and PTX on IGROV1 cell viability. Determination of cell growth was assessed via MTT assays 120 h post treatment. Results are expressed as percentage of an untreated control.